Kanavos, Panos 
ORCID: 0000-0001-9518-3089, Angelis, Aris ORCID: 0000-0002-0261-4634 and Drummond, Michael
(2019)
An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed?
European Journal of Health Economics, 20 (3).
pp. 329-332.
ISSN 1618-7598
Abstract
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness assessment (REA) for pharmaceuticals and medical devices. This cooperation is operationalised through a proposal for a regulation. While a good step in the right direction, this HTA cooperation framework needs to be more explicit and pragmatic about clinical value definition, what constitutes quality of evidence, how real-world evidence is handled, whether the same assessment requirements will apply for medical devices as they do for pharmaceuticals, and how to safeguard consistency in REA interpretation. If demand-rather than supply-driven, this initiative can deliver wider benefits: Europe can improve its power in global drug design and development, while Member States will have at their disposal more resources to assess performance of interventions in their healthcare systems.
| Item Type: | Article |
|---|---|
| Additional Information: | © 2019 the Authors |
| Divisions: | Health Policy LSE Health LSE |
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Date Deposited: | 15 Mar 2019 09:30 |
| Last Modified: | 16 Apr 2024 04:33 |
| URI: | http://eprints.lse.ac.uk/id/eprint/100252 |
Actions (login required)
 |
View Item |
